Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 40 mg/kg subcutaneous dose; 3 cured at 60 days post infection
Antimalarial activity against Plasmodium berghei strain in mice (Mus musculus) by parentral route and change in mean survival time in days was determined at 640 mg/kg subcutaneous dose; 5 cured at 60 days postinfection
Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 80 mg/kg subcutaneous dose; 5 cured at 60 days post infection
Antimalarial activity against Plasmodium berghei strain in mice (Mus musculus) by parentral route and change in mean survival time in days was determined at 160 mg/kg subcutaneous dose; 5 cured at 60 days postinfection
Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 320 mg/kg subcutaneous dose; 5 cured at 60 days post infection
PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line. (Class of assay: confirmatory)
PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line. (Class of assay: confirmatory)
PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line. (Class of assay: confirmatory)
PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line. (Class of assay: confirmatory)